Equities

Akso Health Group

Akso Health Group

Actions
  • Price (USD)0.80
  • Today's Change0.097 / 13.80%
  • Shares traded17.29k
  • 1 Year change+150.00%
  • Beta0.0456
Data delayed at least 15 minutes, as of May 20 2024 15:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.

  • Revenue in USD (TTM)2.20m
  • Net income in USD-17.07m
  • Incorporated2016
  • Employees12.00
  • Location
    Akso Health Group5Th Floor,Block C, Shimao No. 92 Jianguo Road ChaBEIJING 0000ChinaCHN
  • Phone+86 1 053709902
  • Websitehttps://ir.xiaobaimaimai.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DIH Holding US Inc60.30m-1.77m65.68m--------1.09-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Pro-Dex Inc48.24m5.00m66.67m146.0014.022.1711.031.381.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Asensus Surgical Inc8.72m-78.71m70.80m207.00--5.43--8.12-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Vivos Inc18.00k-3.20m71.58m10.00--53.35--3,976.92-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Neuronetics Inc73.23m-27.54m78.29m202.00--2.83--1.07-0.9484-0.94842.520.92260.70612.265.43360,714.30-26.56-28.02-30.98-34.7375.5275.73-37.61-51.045.18-4.270.6825--9.426.2218.76--18.57--
T2 Biosystems Inc7.18m-45.65m86.66m113.00------12.08-17.91-17.912.21-6.850.24973.244.9363,504.43-158.80-106.01---253.03-116.97-12.60-636.09-317.930.1936--10.70---67.75-7.2919.66---20.19--
Vuzix Corp9.94m-49.96m91.91m94.00--1.26--9.25-0.7826-0.78260.15581.130.09971.302.52105,762.30-50.09-41.61-54.56-44.80-35.85-6.13-502.49-317.286.57--0.00--2.488.42-23.02--39.42--
Xtant Medical Holdings Inc91.30m660.00k93.77m207.00--1.8324.461.03-0.0042-0.00420.7550.39451.191.325.78441,072.500.8636-10.381.15-14.6860.7561.080.7229-8.661.22-4.020.2997--57.504.81107.78--18.47--
Sensus Healthcare Inc31.66m4.65m97.21m35.0020.801.9019.743.070.28510.28511.943.120.57211.021.96904,428.608.4110.299.4012.1460.3462.8514.7015.296.49--0.00---45.20-1.58-98.00---23.16--
Fonar Corp102.72m10.29m102.26m561.0010.290.6175.420.99561.481.4814.7224.700.502319.991.41183,098.207.168.737.409.6045.5548.3314.2616.399.16--0.0051--1.083.89-24.71-15.058.48--
Akso Health Group - ADR2.20m-17.07m103.12m12.00------46.81-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
KORU Medical Systems Inc29.32m-13.27m104.34m82.00--5.45--3.56-0.2905-0.29050.64220.41810.89192.386.85357,595.80-40.35-17.60-47.06-20.2960.2459.44-45.24-21.703.37--0.0284--2.2310.44-58.65--11.10--
Myomo Inc19.55m-9.34m104.89m101.00--9.61--5.37-0.2676-0.26760.57750.37861.293.2312.10193,552.80-61.73-81.78-89.94-115.2767.3968.50-47.77-85.762.40--0.00--23.7051.0924.00--2.82--
Vivani Medical Inc0.00-25.65m109.68m44.00--4.90-----0.5042-0.50420.000.40680.00----0.00-52.93-56.58-60.80-67.66-------2,868.72----0.00-------84.69--40.33--
InfuSystem Holdings Inc127.41m84.00k137.14m499.002,316.552.6211.161.080.00280.00285.912.461.2310.666.57255,330.700.08114.600.09555.6950.2756.430.06594.071.511.560.36410.0014.4413.384,744.44--6.01--
Data as of May 20 2024. Currency figures normalised to Akso Health Group's reporting currency: US Dollar USD

Institutional shareholders

0.19%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Mar 2024206.80k0.14%
Millennium Management LLCas of 31 Mar 202426.15k0.02%
Geode Capital Management LLCas of 31 Mar 202414.97k0.01%
RhumbLine Advisers LPas of 31 Mar 202414.35k0.01%
XTX Markets LLCas of 31 Mar 202411.79k0.01%
UBS Securities LLCas of 31 Mar 20241.23k0.00%
Virtu Americas LLCas of 31 Dec 20230.000.00%
Two Sigma Investments LPas of 31 Mar 20240.000.00%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.